Cryptococcus neoformans monoclonal antibody - Albert Einstein College of Medicine
Alternative Names: Anti-Cryptococcus neoformans monoclonal antibody - Albert Einstein College of MedicineLatest Information Update: 12 Dec 2003
At a glance
- Originator Albert Einstein College of Medicine
- Class Monoclonal antibodies
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cryptococcosis
Most Recent Events
- 12 Dec 2003 No development reported - Preclinical for Cryptococcosis in USA (unspecified route)
- 16 Jul 2001 New profile
- 16 Jul 2001 Preclinical development for Cryptococcosis in USA (Unknown route)